Tata Consumer shares jump 3% after Q1 results. Here’s why Nomura, Motilal see strong upside potential
Tata Consumer Products shares rose 3% after the FMCG major reported a 27.8% YoY jump in Q1 FY27 net profit to Rs 427 crore, while revenue increased 11.9% to Rs 5,349 crore. Brokerages remain bullish, with Nomura reiterating a Buy rating and raising its target price to Rs 1,475, citing calibrated price hikes, margin resilience […]
Dr Lal Path Labs shares soar 8% after Q1 earnings beat estimates. What Nomura, Nuvama, other brokerages are saying?
Dr Lal Path Labs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomura, Nuvama and JM Financial raised target prices, citing robust growth outlook, network expansion and improving margins, with continued momentum expected from diagnostics demand and strategic investments.
Hindustan Zinc shares gain 2% as Q1 net profit soars 145% YoY. Should you buy, sell or hold?
Hindustan Zinc shares: The company posted a robust Q1 FY27 performance, prompting several brokerages to reiterate their ‘Buy’ ratings. The Vedanta Group firm’s net profit jumped 145% YoY to Rs 5,469 crore, while revenue surged 77% YoY to Rs 13,747 crore. Total expenses rose 33% YoY to Rs 6,749 crore, reflecting higher operating activity during […]
AU Small Finance Bank shares rally 5% as Q1 PAT jumps 37% to Rs 796 crore, NII up 32% YoY
AU Small Finance Bank share price jumped 5% after it reported a 37% year-on-year rise in net profit to Rs 796 crore for the June quarter, driven by strong growth in net interest income and advances. The lender also announced July 31, 2026, as the record date for its proposed final dividend and elevated COO […]
IDFC First Bank shares soar 9% after Q1 profit jumps 132% to Rs 1,075 crore. What are analysts saying?
IDFC First Bank share price gained 9% after it reported its highest-ever quarterly profit after tax of Rs 1,075 crore. Net interest income rose 21.1% year-on-year, and net interest margin also improved. Gross non-performing assets fell to 1.51%, showing further improvement in asset quality. The bank received claims worth Rs 514.8 crore under the CGFMU […]
Nifty’s 5-day fall may be nearing a reversal; Anand James maps key levels for this week
The consecutive falls that resigned Nifty to a close below lower bollinger band on Friday raises the prospects of a mean reversion move. Further, 20-week SMA at 23741 is also nearby, providing support, should there be weakness early next week. However, weekly oscillators are not positioned to support vertical rise.
Oil Price Today (July 27): Crude oil dips 5%, below $95 as US pauses strikes on Iran. What are experts saying?
Brent crude futures dropped $4.89, or 5.05%, to $91.89, after briefly falling below the key $90 support level earlier in the session. US West Texas Intermediate crude stood at $84.64 a barrel, down $4.67, or 5.23%. The decline comes after crude prices surged 10% last week.
Negative Breakout: These 6 stocks cross below their 200 DMAs
In the NSE list of stocks with a market cap over Rs 10,000 crore, the closing prices of six stocks crossed below their 200 DMA (Daily Moving Averages) on July 24, according to stockedge.com’s technical scan data. Trading below the 200 DMA is considered a negative signal because it indicates that the stock’s price is […]
Global Market Today: Oil falls, Asian stocks rise as Iran tensions ease
Global markets saw oil prices fall and stocks rise as US and Iran paused retaliatory strikes. The dollar weakened against peers while Treasuries gained as inflation concerns receded. Traders now await Federal Reserve interest rate decisions and tech company earnings reports. Central banks globally will emphasize vigilance over higher energy prices impacting inflation. Singapore tightened […]
US market drag keeps Dr Reddy’s, Cipla under pressure despite strong product pipeline
Indian pharmaceutical firms experienced a challenging June quarter, marked by declining US business profits. Dr Reddy’s and Cipla saw significant drops in their net profits and operating margins. However, their domestic businesses continued to perform well, offering a positive outlook. Obesity therapies and specialty product launches are expected to drive future growth for these companies. […]